Corcept Therapeutics (CORT) had the highest return in March 2025 by a mid-cap US stock, returning 86.1%.
Corcept Therapeutics (CORT) had the highest return in March 2025 by a mid-cap US stock, returning 86.1%.
Mid-cap stocks are treated as having a market cap between $2B and $10B.